JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2008, 57(5):195-207

Therapeutic potential of phytocannabinoids and synthetic derivatives affecting human endocannabinoid system

J. Peč1,*, E. Riedingerová2, J. Martin1, Z. Kršková1, J. Dušek1
1 Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmacognosy
2 Palacký University Olomouc, Faculty of Medicine

From the pharmaceutical and medicinal point of view Cannabis sativa L. is an interesting and perspective material. It contains biologically active cannabinoids whose isolation and identification in the 1960's enabled a rapid research that has been bringing interesting results to this day. Especially revealing the human endocannabinoid system and the pharmacological effects of cannabinoids or derived synthetic compounds are the most interesting areas. The research in this field continues also toward pharmaceutical dosage forms with convenient route of administration and pharmacokinetics parameters to be used in clinical practice. Cannabinoids open completely new approaches in the treatment of many relevant human diseases and can become perspective and potential remedies. This review article deals with the effects of cannabinoids on human endocannabinoid system, their use in pharmacotherapy, their adverse effects, their interactions with other drugs and the convenient pharmaceutical dosage forms. Additional information concerning laws valid in the Czech Republic and used analytical forensic methods of cannabinoids are reviewed here as well.

Keywords: Cannabis sativa; cannabinoids; endocannabinoid system; pharmacotherapy; adverse effects; drug interactions; legislation
Grants and funding:

This work was supported by the Research Project MSM 0021620822.

Received: July 7, 2008; Accepted: July 17, 2008; Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Peč J, Riedingerová E, Martin J, Kršková Z, Dušek J. Therapeutic potential of phytocannabinoids and synthetic derivatives affecting human endocannabinoid system. Čes. slov. farm. 2008;57(5):195-207.
Download citation

References

  1. Bruneton, J.: Pharmacognosy, Phytochemistry, Medicinal plants. 2nd ed. Paris, Lavoisier Publishing Inc., 1999, 445-459.
  2. Jahodář, L.: Farmakobotanika, semenné rostliny. Praha, Karolinum, 2006, s. 87.
  3. Guy, G. W., Whittle, B. A., Robson, P. J. eds.: The Medicinal Uses of Cannabis and Cannabinoids. London, Pharmaceutical Press, 2004, s. 71-79, 103-129, 141-197.
  4. http://www.cannabisoffice.nl/eng/index.html,Information for physicians and pharmacists (20. 5. 2008).
  5. Hrdina, V., Hrdina, R., Jahodář, L. et al.: Přírodní toxiny a jedy. Praha, Galén a Karolinum, 2004, s. 87.
  6. Brown, D. T. eds.: Cannabis: the Genus Cannabis. (Medicinal and aromatic plants: industrial profiles; v. 4). Amsterdam, Harwood Academic Publishers, 1998, s. 55-67, 253-272. Go to original source...
  7. Dewick, P. M.: Medicinal Natural Products, A Biosynthetic Approach. 2nd ed. Chichester, J. Wiley & Sons Ltd., 2001, s. 85-89. Go to original source...
  8. ElSohly, M. A., Slade, D.: Life Sci., 2005; 78, 539-548. Go to original source... Go to PubMed...
  9. Russo, E. B.: Chem. Biodiv., 2007; 4, 1614-1648. Go to original source... Go to PubMed...
  10. McPartland, J. M., Russo, E. B.: J. Cannabis. Ther., 2001; 1, 103-132. Go to original source...
  11. Bisogno, T.: J. Neuroendocrinol., 2008; 20 (Suppl. 1), 1-9. Go to original source... Go to PubMed...
  12. Howlett, A. C., Barth, F., Bonner, T. I. et al.: Pharmacol. Rev., 2002; 54, 161-202. Go to original source... Go to PubMed...
  13. Viveros, M. P., Marco E. M., Llorente R. et al.: Neural Plast., 2007; 2007, 1-12. Go to original source... Go to PubMed...
  14. Sander, B., Flygare, J.: Semin. Cancer Biol., 2008; 18, s. 176-189. Go to original source... Go to PubMed...
  15. Labar, G., Micheaux, C.: Chem. Biodiv., 2007; 4, 1882-1902. Go to original source... Go to PubMed...
  16. Wang, J., Ueda, N.: Curr. Opin. Nephrol. Hypertens., 2008; 17, 1-10. Go to original source... Go to PubMed...
  17. Kunos, G.: Am. J. Med., 2007; 120 (9A), S18-S24. Go to original source... Go to PubMed...
  18. Rea, K., Roche, M., Finn, D. M.: Br. J. Pharmacol., 2007; 152, 633-648. Go to original source... Go to PubMed...
  19. Costa, B.: Chem. Biodiv., 2007; 4, 1664-1677. Go to original source... Go to PubMed...
  20. Hashimotodani, Y., Ohno-Shosaku, T., Kano, M.: Curr. Opin. Neurobiol., 2007; 17, 360-365. Go to original source... Go to PubMed...
  21. Fišar, Z.: Chem. Listy, 2006; 100, s. 314-322. Go to original source...
  22. Bisogno, T., Di Marzo, V.: Pharmacol. Res., 2007; 56, 428-442. Go to original source... Go to PubMed...
  23. Hohman, A. G., Suplita, R. L.: AAPS J., 2006; 8 (4), E693-E708. Go to original source... Go to PubMed...
  24. Klein, T., W., Newton, C., T.: Therapeutic Potential of Cannabinoid-Based Drugs. In: Shurin, M., R., Smolkin, Y., S. eds. Immune Mediated Dissease vol. 601. New York, Springer, 2007, s. 395-413. Go to original source...
  25. Pacher, P., Sándor, B., Kunos, G.: Pharmacol. Rev., 2006; 58, 389-462. Go to original source... Go to PubMed...
  26. Benito, C., Tolón, R. M., Pazos, M. R. et al.: Br. J. Pharmacol., 2008; 153, 277-285. Go to original source... Go to PubMed...
  27. Partwee, R. G.: Br. J. Pharmacol., 2008; 153, 199-215.
  28. Ben Amar, M.: J. Ethnopharmacol., 2006; 105, 1-25. Go to original source... Go to PubMed...
  29. Basavarajappa, B. S.: Protein. Pept. Lett., 2007; 14, 237-246. Go to original source... Go to PubMed...
  30. Rouzer, C. A., Lawrence, J. M.: J. Biol. Chem., 2008; 283, 8065-8069. Go to original source... Go to PubMed...
  31. Russo, E. B., Guy, G. F., Robson, P. J.: Chem. Biodiv., 2007; 4, 1729-1743. Go to original source... Go to PubMed...
  32. Hayakawa, K., Mishima, K., Hazekawa, M. et al.: Brain Res., 2008; 1188, 157-164. Go to original source... Go to PubMed...
  33. Mechoulam, R., Peters, M., Murillo-Rodriguez, E. et al.: Chem. Biodiv., 2007; 4, 1678-1692. Go to original source... Go to PubMed...
  34. Micromedex® Healthcare Series, Thomson Micromedex, http://www.thomsonhc.com (20. 5. 2008).
  35. Wright, K. L., Duncan, M., Sharkey, K. A.: Br. J. Pharmacol., 2008; 153, 263-270. Go to original source... Go to PubMed...
  36. Haney, M., Gunderson, E. W., Rabkin, J. et al.: J. Acquir. Immune. Defic. Syndr., 2007; 45, 545-554. Go to original source... Go to PubMed...
  37. Hradec, J.: Remedia, 2005; 2, 163-168. Go to original source...
  38. Bellocchio, L., Vicennati, V., Cervino, C. et al.: Am. J. Cardiol., 2007; 100 (Suppl.), s. 7P-17P. Go to original source... Go to PubMed...
  39. http://www.sukl.cz/modules/medication/search.php (20. 5. 2008, Acomplia).
  40. Mikro-verze AISLP - ČR, 2008.1 pro MS Windows.
  41. Mitchel, P., B., Morris, M., J.: Lancet, 2007; 370, s. 1671-1672. Go to original source... Go to PubMed...
  42. http://www.sukl.cz/sukl-upozornuje-na-kontraindikace-u-pripravku-acomplia (20. 5. 2008).
  43. Pan, H. L., Wu, Z. Z., Zhou, H. Y. et al.: Pharmacol. Ther., 2008; 117, 141-161. Go to original source... Go to PubMed...
  44. Nurmikko, T. J., Serpell, M. G., Hoggart, B. et al.: Pain, 2007; 133, 210-220. Go to original source... Go to PubMed...
  45. Lienau, F. S., Füllgraf, H., Moser, A. et al.: Eur. J. Neurol., 2007; 14, 1162-1169. Go to original source... Go to PubMed...
  46. http://www.gwpharm.com/sativex.asp (20. 5. 2008).
  47. Docagne, F., Mestre, L., Loría, F. et al.: Expert Opin. Ther. Targets, 2008; 12, 185-189. Go to original source... Go to PubMed...
  48. Smith, P. F.: Expert. Rev. Neurother., 2007; 7, 1157-1163. Go to original source... Go to PubMed...
  49. Papathanasopoulos, P., Messinis, L., Lyros, E. et al.: J. Neuropsychiatry Clin. Neurosci., 2008; 20, 36-51. Go to original source...
  50. Centonze, D., Finazzi-Agró, A., Bernardi, G. et al.: Trends Pharmacol. Sci., 2007; 28, 180-187. Go to original source... Go to PubMed...
  51. Micale, V., Mazzola, C., Drago, F.: Pharmacol. Res., 2007; 56, 382-392. Go to original source... Go to PubMed...
  52. Gilbert, G. L., Kim, H. J., Waataja, J. J. et al.: Brain Res., 2007; 1128, 61-69. Go to original source... Go to PubMed...
  53. Seamon, M. J., Fass, J. A., Maniscalco-Feichtl, M. et al.: Am. J. Health-Syst. Pharm., 2007; 64, 1037-1044. Go to original source... Go to PubMed...
  54. Kunos, G., Gao, B.: Gastroenterology, 2008; 134, 622-625. Go to original source... Go to PubMed...
  55. Hézode, C., Zafrani, E. S., Roudot-Thoraval, F. et al.: Gastroenterology, 2008; 134, 432-439. Go to original source... Go to PubMed...
  56. Ricci, G., Cacciola, G., Altucci, L. et al.: Gen. Comp. Endocrinol., 2007; 153, 320-322. Go to original source... Go to PubMed...
  57. Harkany, T., Guzmán, M., Galve-Roperh, I. et al.: Trends. Pharmacol. Sci., 2006; 28, 83-92. Go to original source... Go to PubMed...
  58. Solinas, M., Yasar, S., Goldberg, S. R.: Pharmacol. Res., 2007; 56, 393-405. Go to original source... Go to PubMed...
  59. Fattore, L., Fadda, P., Fratta, W.: Pharmacol. Res., 2007; 56, 418-427. Go to original source... Go to PubMed...
  60. Saario, S. M., Laitinen, J. T.: Bas. Clin. Pharma. & Tox., 2007; 101, 287-293. Go to original source... Go to PubMed...
  61. Huestis, M., A.: Chem. Biodiv., 2007; 4, 1770-1804. Go to original source... Go to PubMed...
  62. Kalant, H.: Clin. Pharmacol. Ther., 2008; 83, 517-519. Go to original source... Go to PubMed...
  63. Aldington, S., Harwood, M., Cox, B. et al.: Eur. Respir. J., 2008; 31, 280-286. Go to original source... Go to PubMed...
  64. Aldington, S., Harwood, M., Cox, B. et al.: Otolaryngol. Head Neck Surg., 2008; 138, 374-380. Go to original source... Go to PubMed...
  65. Hazekamp, A., Ruhaak, R., Zuurman, L. et al.: J. Pharm. Sci., 2006; 95, 1308-1317. Go to original source... Go to PubMed...
  66. http://www.storz-bickel.com/vaporizer/volcano-vaporization-system.html# (20. 5. 2008).
  67. Dussy, F. E., Hamberg, C., Luginbühl, M. et al.: Forensic. Sci. Int., 2005; 149, 3-10. Go to original source... Go to PubMed...
  68. Evans, W. C. (eds.): Trease and Evans Pharmacognosy. 15th ed. Edinburg, W. B. Saunders, 2002, s. 51, 53-54, 501-503.
  69. Hazekamp, A., Bastola, K., Rashidi, H. et al.: J. Ethnopharmacol., 2007; 113, 85-90. Go to original source... Go to PubMed...
  70. http://www.mze.cz/, Situační a výhledová zpráva len a konopí, červen 2007 (20. 5. 2008).
  71. Hazekamp, A.: Cannabinoids, 2006; 1, 1-9.
  72. http://www.psp.cz/sqw/text/tiskt.sqw?O=5&CT=410&CT1=0 (20. 5. 2008).
  73. http://www.drogy-info.cz/index.php/info/drogy_a_zakon (20. 5. 2008).
  74. Kabátová, N.: Bulletin Národní referenční laboratoře; 2005, IX(3), s. 33-58.
  75. Zákon o návykových látkách č. 167/1998 Sb.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.